Clinical Trials Update: May 23, 2005
Healthy Women Studies Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Ulcerative Colitis
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Healthy Women Studies
This trial requires healthy females to dose with an investigational medication and with a birth control pill. Various clinical assessments will be completed, including but not limited to safety and tolerability of the medications. Requirements are healthy females, ages 18-40, not diagnosed with chronic medial conditions, not taking prescription medications within 14 days of the study, height/weight proportionate, nonsmoker, able to pass a urine drug screen and available for overnight stays and outpatient visits. Research site located in Tacoma, Wash.
Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
The purpose of this research study is to determine whether AMG 531 is safe and effective as a treatment of thrombocytopenia in patients with ITP who have had a splenectomy. You may be able to participate if you are male or female at least 18 years old, have been diagnosed with ITP (Immune Thrombocytopenic Purpura), have had a splenectomy for the treatment of ITP and meet additional criteria. Research site located in New York, NY.
A global medical research study is underway to evaluate the safety and effectiveness of an investigational drug to maintain ulcerative colitis remission. Ulcerative colitis patients may be eligible for the study if they are between the ages of 18 and 80, now in remission, and have been treated for a flare-up of ulcerative colitis within the last 12 months. Research site located in Charlottesville, Va.
Copyright 2005 CenterWatch. All rights reserved.